Blackstone Inc. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 174 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
Blackstone Inc. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$34,747,254
+12.1%
340,7930.0%0.15%
+17.3%
Q1 2023$30,984,900
+139.3%
340,7930.0%0.13%
+159.2%
Q4 2022$12,946,726
+151076.2%
340,7930.0%0.05%
+53.1%
Q3 2022$8,564
-99.9%
340,7930.0%0.03%
-5.9%
Q2 2022$10,357,000
-7.2%
340,7930.0%0.03%
+21.4%
Q1 2022$11,164,000
+24.2%
340,7930.0%0.03%
+21.7%
Q4 2021$8,987,000
-73.8%
340,7930.0%0.02%
-69.7%
Q3 2021$34,287,000
-28.9%
340,7930.0%0.08%
-30.3%
Q2 2021$48,232,000
+42.0%
340,7930.0%0.11%
+60.3%
Q1 2021$33,977,000
-19.4%
340,7930.0%0.07%
-54.1%
Q4 2020$42,129,000
+81.3%
340,793
+42.9%
0.15%
+64.4%
Q3 2020$23,240,000
-46.6%
238,555
-14.5%
0.09%
-51.1%
Q2 2020$43,543,000279,0850.18%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders